Omega-3 Pills Cut Heart Attacks but Not Cancer in Large Trial
Graded Moderate — a large trial of 25,871 people assigned by chance for about five years; the main goal was missed and the heart attack findings come from secondary goals.
- Design
- Randomized controlled trial
- Participants
- 25,871
- Duration
- 5.3 years
- Funding
- —
In the VITAL trial, older adults taking 1 gram of omega-3 a day had fewer heart attacks but no fewer cancers.
A daily fish oil capsule lowered the risk of a heart attack by 28 percent in older Americans. Yet the trial missed its main goal. Major cardiovascular events overall did not become clearly less common. Cancer and deaths from any cause did not drop either.
The trial, called VITAL, enrolled 25,871 men aged 50 and over and women aged 55 and over. They were not picked for being at high risk. Chance decided who took 1 gram of omega-3 a day and who took a dummy pill. The typical participant stayed on it for 5.3 years. Fatal heart attacks were cut in half, though that figure is very uncertain. The risk of autoimmune disease, where the immune system attacks the body itself, was 18 percent lower.
Black participants and people who ate little fish seemed to benefit more. Effects differed between women and men. The heart attack results were secondary goals of the trial, so they carry less weight than the main result. The authors say the findings do not support routine omega-3 pills for healthy adults. For people who eat little fish, they think targeted use deserves consideration.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
